Products & ReviewClinical Diagnostics

PreCursor-M+

Fujirebio81352Available: ,Western Europe,Asia,Eastern Europe,South Central America,Middle East,Africa,

Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.

Fujirebio

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review

Sample types:

  • Bisulfite-converted DNA isolated from physician collected cervical specimens or self-collected vaginal specimens

Clinical performance - Long-term data:

  • Most evaluated and validated methylation assay to identify HPV positive women with progressing cervical disease in direct need for colposcopy or other follow-up procedures1,2
  • Demonstrating very high sensitivity for cervical cancer detection (95.0-100%) in HPV-positive cervical specimens2,3,4
  • Longitudinal data: The long-term risk for cancer with a negative PreCursor-M+ is lower than with a negative cytology result; for CIN3 the long-term risk is similar as cytology5,6

Flexible:

  • Suitable for various sample types, including self-samples and common Liquid Based Cytology media types
  • Compatible with standard DNA extraction methods

Reliable:

  • Build-in check for sample quality ensuring reliable results

Product Overview

Links